Patents by Inventor Kevin Qu

Kevin Qu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR SCREENING SOLID TUMORS
    Publication number: 20180142304
    Abstract: The present technology relates to methods for determining whether a patient diagnosed with breast cancer, colorectal cancer, melanoma or lung cancer will benefit from or is predicted to be responsive to treatment with an individual therapeutic agent or a specific combination of therapeutic agents. These methods are based on screening a patient's solid tumors and detecting alterations in target nucleic acid sequences corresponding to a specific set of cancer-related genes. Kits for use in practicing the methods are also provided.
    Type: Application
    Filed: October 28, 2015
    Publication date: May 24, 2018
    Applicant: Quest Diagnostics Investments Incorporated
    Inventors: Heather SANDERS, Kevin QU, James PRENTICE, Frederic WALDMAN
  • Circulating microRNA as a marker for hepatocellular carcinoma
    Patent number: 9840741
    Abstract: Provided herein are methods for the diagnosis, or management of liver diseases, e.g. hepatocellular carcinoma, using profiles of the miRNAs determined from cellular or acellular body fluids.
    Type: Grant
    Filed: March 14, 2011
    Date of Patent: December 12, 2017
    Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
    Inventors: Kevin Qu, Ke Zhang, Maher Albitar
  • MICRORNA PROFILING FOR DIAGNOSIS OF DYSPLASTIC NEVI AND MELANOMA
    Publication number: 20170088899
    Abstract: Provided herein are methods for miRNA profiling for the diagnosis, prognosis, and management of melanoma and differentiation of melanoma from nevi.
    Type: Application
    Filed: August 5, 2016
    Publication date: March 30, 2017
    Applicant: Quest Diagnostics Investments Incorporated
    Inventors: Kevin Qu, Anthony Sferruzza, Ke Zhang, Yan Liu, Renius Owen
  • MICRORNA PROFILING FOR DIAGNOSIS OF DYSPLASTIC NEVI AND MELANOMA
    Publication number: 20170081725
    Abstract: Provided herein are methods for miRNA profiling for the diagnosis, prognosis, and management of melanoma and differentiation of melanoma from nevi.
    Type: Application
    Filed: August 18, 2016
    Publication date: March 23, 2017
    Applicant: Quest Diagnostics Investments Incorporated
    Inventors: Kevin Qu, Anthony Sferruzza, Ke Zhang, Yan Liu, Renius Owen
  • Microrna profiling for diagnosis of dysplastic nevi and melanoma
    Patent number: 9447471
    Abstract: Provided herein are methods for miRNA profiling for the diagnosis, prognosis, and management of melanoma and differentiation of melanoma from nevi.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: September 20, 2016
    Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
    Inventors: Kevin Qu, Anthony Sferruzza, Ke Zhang, Yan Liu, Renius Owen
  • CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA
    Publication number: 20110281268
    Abstract: Provided herein are methods for the diagnosis, or management of liver diseases, e.g. hepatocellular carcinoma, using profiles of the miRNAs determined from cellular or acellular body fluids.
    Type: Application
    Filed: March 14, 2011
    Publication date: November 17, 2011
    Inventors: Kevin Qu, Ke Zhang, Maher Albitar
  • UBIQUITIN PROTEASOME SYSTEM PROFILING FOR DIAGNOSIS OF CHRONIC LIVER DISEASE
    Publication number: 20110269162
    Abstract: Provided herein are methods for the diagnosis, staging, prognosis, or management of liver disease, e.g. chronic liver disease, and other diseases using profiles of the ubiquitin-proteasome system determined from acellular body fluids or cell-containing samples. Further provided are methods of predicting response to therapy in certain populations of patients with liver disease.
    Type: Application
    Filed: October 26, 2010
    Publication date: November 3, 2011
    Inventors: Maher Albitar, Wanlong Ma, Ke Zhang, Xi Zhang, Xiuqiang Wang, Kevin Qu, Anthony Sferruzza
  • CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA
    Publication number: 20110223607
    Abstract: Provided herein are methods for the diagnosis, or management of liver diseases, e.g., hepatocellular carcinoma, using profiles of the miRNAs determined from cellular or acellular body fluids.
    Type: Application
    Filed: March 11, 2011
    Publication date: September 15, 2011
    Inventors: Kevin Qu, Ke Zhang, Maher Albitar
  • UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS
    Publication number: 20110053197
    Abstract: Provided herein are methods for the diagnosis, prognosis, or management of neoplastic diseases, i.e. cancer, and other diseases using profiles of the ubiquitin-proteasome system determined from acellular body fluids or cell-containing samples. Further provided are methods of predicting response to therapy in certain populations of cancer patients.
    Type: Application
    Filed: August 25, 2009
    Publication date: March 3, 2011
    Inventors: Maher Albitar, Wanlong Ma, Ke Zhang, Xi Zhang, Xiuqiang Wang, Kevin Qu, Anthony Sferruzza
  • UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS
    Publication number: 20110053199
    Abstract: Provided herein are methods for the diagnosis, prognosis, or management of neoplastic diseases, i.e. cancer, and other diseases using profiles of the ubiquitin-protcasome system determined from acellular body fluids or cell-containing samples. Further provided are methods of predicting response to therapy in certain populations of cancer patients.
    Type: Application
    Filed: August 23, 2010
    Publication date: March 3, 2011
    Inventors: Maher Albitar, Wanlong Ma, Ke Zhang, Xi Zhang, Xiuqiang Wang, Kevin Qu, Anthony Sferruzza